Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the TactiFlex(TM) Ablation Catheter, Sensor Enabled(TM) (TactiFlex SE) for Treating Drug-refractory, Symptomatic Atrial Fibrillation.

NCT04356040 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT04356040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04356040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the TactiFlex(TM) Ablation Catheter, Sensor Enabled(TM) (TactiFlex SE) for Treating Drug-refractory, Symptomatic Atrial Fibrillation.
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
June 29, 2020
Completion date
July 1, 2022
Enrollment
355 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation